If you need more lookups,
subscriptions start at $34 USD/month.
Max Location
California, United States
Max Work
Director of Translational Oncology - Clinical Development @ (September 2024 - Present)
Executive Director of Medical Information, Medical Affairs @ (November 2020 - September 2024)
Director, Medical Communications @ (June 2019 - November 2020)
Director of Medical Affairs @ Roche Sequencing Solutions, Inc. (September 2017 - May 2019)
Director, Project Leader, Oncology @ Roche Sequencing Solutions, Inc. (January 2016 - September 2017)
Research Leader @ (August 2011 - January 2016)
Scientist @ (August 2008 - August 2011)
Postdoc @ (May 2004 - August 2008)
Max Education
University of Rochester School of Medicine and Dentistry
PhD (Biochemistry)
2000-2004
Nanjing University and China Pharmaceutical University, A joint program
Bachelor of Science (BS) (Biotechemistry and Biopharmaceutical Sciences)
1994-1998
Max Skills
Vendor Management
Defining Requirements
Quality Assurance Processes
Vendor Relations
Strategic Communications
Regulatory Guidelines
Publications
Publication Development
Industry Training
Health Care Professionals
Content Development
Drug Discovery
Assay Development
Biochemistry
Biomarkers
Genomics
Molecular Biology
Protein Chemistry
Cell Culture
Cell
Cell Biology
Oncology
Biotechnology
Drug Development
Bioinformatics
Protein Expression
Molecular Diagnostics
NextGen Sequencing
Max Summary
Max, based in California, United States, is currently a Director of Translational Oncology - Clinical Development at ALX Oncology. Max brings experience from previous roles at Coherus BioSciences, Foundation Medicine and Roche Sequencing Solutions, Inc.. Max holds a 2000 - 2004 PhD in Biochemistry @ University of Rochester School of Medicine and Dentistry. With a robust skill set that includes Vendor Management, Defining Requirements, Quality Assurance Processes, Vendor Relations, Strategic Communications and more. Max has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Max?
Find contact details for 700 million professionals.